Search research articles
Contact Us
Filters
Showing results (611-620 of 681) with videos related to
Page
of 69
Sort By:
Vaccine: X
|
April 28, 2020
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Thomas P Monath, Jeroen Kortekaas, Douglas M Watts, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2015
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI
Samuel J Klempner, Lyudmila A Bazhenova, Fadi S Braiteh, et al.
Nature Communications
|
September 13, 2023
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
Nathaniel S Chapman, Ruben J G Hulswit, Jonna L B Westover, et al.
Research Square
|
April 10, 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection
Samantha R Wasson, Yanan Liu, Minghao Li, et al.
Osteoarthritis and Cartilage
|
November 9, 2000
FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis
I E James, S Kumar, M R Barnes, et al.
Plos Pathogens
|
February 17, 2026
Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain
Guido C Paesen, Nathaniel S Chapman, Jonna B Westover, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo
B J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry
|
January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro
I E James, R W Marquis, S M Blake, et al.
Development (Cambridge, England)
|
March 21, 2008
The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome
Regina Raz, Sigmar Stricker, Elizabetta Gazzerro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2021
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
Nathaniel S Chapman, Haiyan Zhao, Nurgun Kose, et al.
Page
of 69
Search research articles
Search
Showing results (611-620 of 681) with videos related to
Sort By:
Page
of 69
Vaccine: X
|
April 28, 2020
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Thomas P Monath, Jeroen Kortekaas, Douglas M Watts, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2015
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI
Samuel J Klempner, Lyudmila A Bazhenova, Fadi S Braiteh, et al.
Nature Communications
|
September 13, 2023
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
Nathaniel S Chapman, Ruben J G Hulswit, Jonna L B Westover, et al.
Research Square
|
April 10, 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection
Samantha R Wasson, Yanan Liu, Minghao Li, et al.
Osteoarthritis and Cartilage
|
November 9, 2000
FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis
I E James, S Kumar, M R Barnes, et al.
Plos Pathogens
|
February 17, 2026
Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain
Guido C Paesen, Nathaniel S Chapman, Jonna B Westover, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo
B J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry
|
January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro
I E James, R W Marquis, S M Blake, et al.
Development (Cambridge, England)
|
March 21, 2008
The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome
Regina Raz, Sigmar Stricker, Elizabetta Gazzerro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2021
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
Nathaniel S Chapman, Haiyan Zhao, Nurgun Kose, et al.
Page
of 69